miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1

BACKGROUND: Sorafenib can prolong the survival of patients with advanced hepatocellular carcinoma (HCC). However, drug resistance remains the main obstacle to improving its efficiency. This study aimed to explore the likely molecular mechanism of sorafenib resistance. METHODS: Differentially express...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wenliang, Lin, Zhirong, Chen, Xianqing, Li, Wenxin, Zhu, Sicong, Wei, Yingcheng, Huo, Liyun, Chen, Yajin, Shang, Changzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859776/
https://www.ncbi.nlm.nih.gov/pubmed/33553331
http://dx.doi.org/10.21037/atm-20-2081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859776/
https://www.ncbi.nlm.nih.gov/pubmed/33553331
http://dx.doi.org/10.21037/atm-20-2081

Ejemplares similares